How to Buy Actinium Pharmaceuticals Stock
Actinium Pharmaceuticals Inc
Actinium Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or adoptive cell therapies.
Actinium Pharmaceuticals stock last closed at $1.64, down 0.61% from the previous day, and has decreased 22.64% in one year. It has overperformed other stocks in the Biotechnology industry by 0.4 percentage points. Actinium Pharmaceuticals stock is currently +59.38% from its 52-week low of $1.03, and -31.95% from its 52-week high of $2.41.
As of Aug 20, 2025, there are 31.2M shares of ATNM outstanding. The market capitalization of ATNM is $51.16M. In the past 24 hours, 52,700 ATNM shares were traded.
How to Buy Actinium Pharmaceuticals Stock
Wondering how to invest in Actinium Pharmaceuticals stock? Here's how.
- Decide where to buy Actinium Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you choose where to buy Actinium Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Pick your payment method and add your info.
- Analyze Actinium Pharmaceuticals stock: The Actinium Pharmaceuticals ticker symbol is ATNM. Is Actinium Pharmaceuticals stock a good investment? Should you buy shares of ATNM? How do ATNM's underlying business fundamentals look? Do top analysts think Actinium Pharmaceuticals is a good buy? Why has ATNM's stock price moved recently? (Hint: Our stock market research tools can help you figure out if ATNM is a good stock to buy).
- Execute your ATNM trade: Decide if you will purchase ATNM shares at the current market price or use a limit order to purchase ATNM stock at a given price.
- Keep tabs on your ATNM position: Create a watchlist to the latest updates on your position in Actinium Pharmaceuticals stock.
Step 1: Decide where to buy Actinium Pharmaceuticals stock
You will need a brokerage account in order to access the NYSEMKT market and buy ATNM stock.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal details so you are able to invest in ATNM stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start a new trading account.
- Send your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on stock market apps, you need to deposit funds:
Check out the walkthrough below for more details depositing money into your new investment account.
Step 4: Analyze Actinium Pharmaceuticals stock
Once you have identified the best place to buy Actinium Pharmaceuticals stock, it's crucial to research their stock before you invest, so you truly comprehend the risk as well as the opportunity.
Actinium Pharmaceuticals quick stats
Fundamentals of Actinium Pharmaceuticals
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on ATNM's stock page.
Is ATNM stock undervalued or overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ATNM's fair value.
Using relative valuations metrics:
- ATNM could be undervalued based on its P/B ratio of 1.99x, relative to Biotechnology industry P/B ratio of 4.5x
You can do additional valuation analysis on ATNM's stock here.
ATNM Financial Summary
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the ATNM balance sheet.
- Total ATNM debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the ATNM balance sheet.
- ATNM has cash burn of 33272000. It has enough cash and short-term investments to cover this for at least one year.
- ATNM has $65.33M in cash and short term investments. This is enough to cover its annual cash burn of $33.27M.
Failed Financial Due Diligence Checks:
- ATNM has a relatively high debt to equity ratio of 1.67.
Is ATNM stock a Buy, Hold, or Sell, according to analysts?
Out of 1 Equities analysts who research ATNM, the consensus analyst rating on Actinium Pharmaceuticals is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Actinium Pharmaceuticals stock forecast page.
ATNM Trading Indicators
ATNM Growth Numbers
Last year, ATNM revenue was $0.00. Over the past four year, ATNM's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 64.6%.
You can research ATNM's earnings and revenue performance here.
What are ATNM insiders up to?
In the last year, executives and large shareholders at ATNM have sold more shares than they have bought.
Sandesh Seth, Chief Executive Officer of ATNM, was the latest ATNM insider to sell. They sold $206,739.00 worth of ATNM shares on Aug 18, 2025.
Research more about who owns ATNM shares here.
Does ATNM provide a stable income stream?
No, Actinium Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your ATNM trade
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the easiest way to buy. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, use a limit order.
Click the Open button and your broker will place the order.
If you want more assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your ATNM position
Now that you own some shares in ATNM, you'll want to keep up with your company.
Start a watchlist to keep tabs on your ATNM stock.
ATNM Feed
How to Buy Stock in Actinium Pharmaceuticals
To reiterate, here are the 6 steps to buy stock in Actinium Pharmaceuticals:
- Decide where to buy Actinium Pharmaceuticals stock
- Create your brokerage account
- Deposit funds into your investment account
- Analyze Actinium Pharmaceuticals stock
- Execute your ATNM trade
- Keep tabs on your ATNM position
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to track your investment in Actinium Pharmaceuticals, add ATNM to your watchlist by clicking the button below.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.